BBHC
LEGN icon

Brown Brothers Harriman & Co’s Legend Biotech LEGN Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$16.3K – 1396
2024
Q4 		$16.3K Buy
+500
New +$20.7K ﹤0.01% 1061

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Brothers Harriman & Co's LEGN Position: Q1 2025 in Review

Brown Brothers Harriman & Co sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 500 shares — an estimated $16.3K sold.

Brown Brothers Harriman & Co first reported a position in LEGN in Q4 2024 and held it in 1 quarter. The position peaked at $16.3K in Q4 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Brown Brothers Harriman & Co reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 500 Legend Biotech shares in Q1 2025, an estimated $16.3K.
  • Brown Brothers Harriman & Co first reported a position in Legend Biotech in Q4 2024 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Legend Biotech position peaked at $16.3K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2025, filed 14 May 2025.